Takekazu Aoyama - Concepedia

Author

Takekazu Aoyama

Also Known As

T Aoyama, T. Aoyama, TAKEKAZU AOYAMA, Takekazu Aoyama

Publications

348

Citations

H-Index

Concepts

All Affiliations

Takekazu Aoyama is an author at Hospital Universitario 12 De Octubre specializing in cancer therapeutics, oncology, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	44
2	Gastroenterology	1	1	44
3	Cancer Therapeutics	1	1	44
4	Oncology	1	1	44
5	Radiation Oncology	1	1	44

Takekazu Aoyama

Publications

267

Citations

H-Index

Page 1

	Year	Citations
Protracted survival after resection of metastatic uveal melanoma Takekazu Aoyama, Michael J. Mastrangelo, David Berd, Cancer	2000	133
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial Martin Reck, Tudor–Eliade Ciuleanu, Michael Schenker, European Journal of Cancer	2024	57
A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer Jaffer A. Ajani, Mikhail Abramov, Igor Bondarenko, Annals of Oncology Gastrointestinal OncologyMedicinePhase Iii TrialGastroenterologyIntravenous 5-Fluorouracil/cisplatin	2017	44
Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab–Based Treatment in Patients With Metastatic NSCLC and Tumor Programmed Death-Ligand 1 Lower Than 1%: A Pooled Analysis Solange Peters, Luis Paz‐Ares, Martin Reck, Journal of Thoracic Oncology	2024	22
Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA David P. Carbone, Tudor–Eliade Ciuleanu, Manuel Cobo, ESMO Open	2025	11

Page 1